Moreover, Christoph et al. demonstrated that RANK, RANKL, and OPG are expressed by primary prostate cancer cells and their expression levels significantly correlate with the Gleason score, serum prostate-specific antigen (PSA) levels, and disease progression [9]. The gene discussed is TNFRSF11A; the disease is Familial prostate cancer.